STAT3 and acute myeloid leukemia: Accordingly, treatment of NOMO-1 with STAT3-inhibitor AG490 resulted in reduced STAT3-phosphorylation and concomitant downregulation of NANOG (Fig 7B), indicating that STAT3 activated NANOG in this AML cell line as well.